NCT01356017

CKD-828 Drug Interaction Study (Telmisartan)

A Randomized, Open-label, Multiple Doses, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction and Safety of Telmisartan Between Free Combination of Telmisartan and S-amlodipine and Telmisartan Monotherapy in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (estimated)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: Male
• Age: 20 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the Pharmacokinetic drug interaction and safety of Telmisartan between free combination of Telmisartan and S-amlodipine and Telmisartan monotherapy.

Conditions

• Healthy Male Volunteers

Interventions

Type	Name	Description
DRUG	Telmisartan 80mg, S-amlodipine 5mg	Telmisartan 80mg and S-amlodipine 5mg, Oral, Once a day, for 9 days + Wash out (19 days)
DRUG	Telmisartan 80mg	Telmisartan 80mg, Oral, Once a day, for 9 days + Wash out (19 days)

Timeline

• Start date: 2011-06-01
• Primary completion: 2011-09-01
• Completion: 2011-09-01
• First posted: 2011-05-19
• Last updated: 2011-09-07

Locations

1 site across 1 country: South Korea